Warren C. Stern
Corporate Officer/Principal chez HO2.1 Annex Fund LP
Profil
Warren C.
Stern is the founder of HO2.1 Annex Fund LP, Advanced Pain Remedies, Inc. Prior to founding these companies, he held several senior vice president positions in scientific and medical services at Forest Laboratories, Inc., PAREXEL International Corp., DOV Pharmaceutical, Inc., Pharmatec, Inc., Cato Research LLC, and The Burroughs Wellcome Fund.
He earned a doctorate degree from Indiana University in 1969.
Postes actifs de Warren C. Stern
| Sociétés | Poste | Début |
|---|---|---|
| HO2.1 Annex Fund LP | Corporate Officer/Principal | - |
Anciens postes connus de Warren C. Stern
| Sociétés | Poste | Fin |
|---|---|---|
Advanced Pain Remedies, Inc.
 Advanced Pain Remedies, Inc. BiotechnologyHealth Technology Advanced Pain Remedies, Inc. operates as a biotechnology company. It focuses on treating intractable chronic pain. The company was founded on October 21, 2010 and is headquartered in Durham, NC. | Fondateur | 14/03/2011 |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Directeur Technique/Scientifique/R&D | - |
| Pharmatec, Inc. | Directeur Technique/Scientifique/R&D | - |
| FOREST LABORATORIES, INC. | Directeur Technique/Scientifique/R&D | - |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Directeur Technique/Scientifique/R&D | - |
Formation de Warren C. Stern
| Indiana University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |
| Pharmatec, Inc. | Health Technology |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
| HO2.1 Annex Fund LP | Finance |
Advanced Pain Remedies, Inc.
Advanced Pain Remedies, Inc. BiotechnologyHealth Technology Advanced Pain Remedies, Inc. operates as a biotechnology company. It focuses on treating intractable chronic pain. The company was founded on October 21, 2010 and is headquartered in Durham, NC. | Health Technology |
